Neonatal Non-Invasive Hemoglobin Determination

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2011-09-30

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate hemoglobin (Hgb) measurement by Masimo-developed pulse co-oximetry in pediatric patients weighing less than 3 kilograms (Kg).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Measurement of Total Hemoglobin by Pulse Oximetry in Neonatal Population

NCT03120702

Anemia

COMPLETED NA

Haemoglobin Measurement for Babies

NCT02722759

Hemoglobins Infant Non-invasive

COMPLETED NA

Fetal Haemoglobin and Cerebral and Peripheral Oxygenation.

NCT04802629

Preterm Birth Oxygen Toxicity Fetal Hemoglobin

COMPLETED

Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations

NCT07223177

SpO2

RECRUITING NA

Comparing Validity of Non-Invasive Hemoglobin Monitoring to Laboratory Results in Critically Ill Children

NCT01750463

Hemoglobin Results

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This collaborative study with Masimo Corporation will involve 2 phases. In the first phase of this study, 25 subjects weighing 0.5 to 3.0 kg will be recruited and hemoglobin values will be obtained from the non-invasive probe at the same time as blood samples are routinely drawn for Hgb analysis using the cyanomethemoglobin method (ADVIA 2121). Masimo Corporation will use this data to calibrate or modify the hemoglobin reading (SpHb®) sensors and monitors. All results and conclusions from this phase will be discussed with the investigation team in order to determine if additional subjects are needed (at increments of 25 subjects at a time). Once the sensor designs have been optimized, another group of patients will be studied to document the accuracy and precision of the hemoglobin reading (SpHb®) measurements.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgical Procedures Infant, Newborn Infant, Low Birth Weight

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Neonate

Subjects admitted for surgery or to the pediatric intensive care unit (PICU) or neonatal intensive care unit (NICU) who require daily and/or multiple blood samples for hemoglobin measurement.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Males or females weighing 0.5 kg to 3 kg.
2. Neonates and infants and children admitted to the Children's Hospital of Philadelphia (CHOP)operating room (OR), PICU and NICU where hemoglobin measurements are anticipated.
3. Parental/guardian permission (informed consent)

Exclusion Criteria

1. Subjects where blood samples are obtained through access types other than venous or arterial (e.g: intraosseous).
2. Subject weighing more than 3 kg.
3. Subjects who are too small or with any anatomical limitations that would preclude proper attachment of the adhesive sensor.
4. Any skin rash on the intended site of measurement. Severe allergy to adhesive tapes.

Maximum Eligible Age

1 Year

Eligible Sex

ALL

Accepts Healthy Volunteers

No